TILS.L Net Margin

The Net Margin of Tiziana Life Sciences PLC (TILS.L) is -589.47%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

TILS.L Net Margin - Historical Value

Date	Value
2020-12-31	-589.47%
2019-12-31	325.00%
2018-12-31	975.00%

TILS.L Net Margin - Peers Comparison

Ticker	Name	Value
BVXP.L	Bioventix PLC	57.83%
OXB.L	Oxford Biomedica PLC	-33.53%
PCIB.OL	PCI Biotech Holding ASA	-243.76%
IMCR	Immunocore Holdings PLC	-16.47%
POXEL.PA	Poxel SA	-275.84%
SANION.ST	Saniona AB	56.39%
SCLP.L	Scancell Holdings PLC	-254.72%
ABC.L	Abcam PLC	3.72%
HPHA.DE	Heidelberg Pharma AG	-282.98%
VVY.AS	Vivoryon Therapeutics NV	-117.57%
GNS.L	Genus PLC	2.87%
XSPRAY.ST	XSpray Pharma AB (publ)	-8338.63%
ABVX.PA	Abivax SA	-50800.00%
BINV.ST	BioInvent International AB	-960.87%
ETX.L	E-Therapeutics PLC	-1741.89%
FARN.L	Faron Pharmaceuticals Oy	-105715.80%
ORY.MC	Oryzon Genomics SA	-26000.00%
SLN.L	Silence Therapeutics PLC	-594.03%
BCYC	Bicycle Therapeutics PLC	-479.18%
CNTA	Centessa Pharmaceuticals PLC	-2204.65%
MDXH.BR	MDxHealth SA	-118.86%
SIGHT.PA	Gensight Biologics SA	-933.40%
ADAP	Adaptimmune Therapeutics PLC	-39.78%
ALQGC.PA	Quantum Genomics SA	-31520.38%
BGBIO.OL	Bergenbio ASA	-16424.76%
DMYD B.ST	Diamyd Medical AB	-130597.69%
EGTX.ST	Egetis Therapeutics AB (publ)	-745.12%
MYOV	Myovant Sciences Ltd	-89.18%
XBRANE.ST	Xbrane Biopharma AB	-133.97%
KDS.AS	Kiadis Pharma NV	-468.23%
MAB.WA	Mabion SA	-9.18%
NANOV.OL	Nordic Nanovector ASA	-97289.40%
OSE.PA	OSE Immunotherapeutics SA	44.88%
VSC.DE	4Sc AG	-72.56%